Students find dangerous DNA levels in COVID vaccines


Listen To Story Above

A group of Virginia high school students working alongside the FDA has made a startling discovery regarding DNA contamination in Pfizer’s COVID-19 mRNA vaccines, both experimental and commercial versions.

Publishing their findings in the Journal of High School Science on December 29th, students from Centreville High School – Tyler Wang, Alex Kim, and Kevin Kim – utilized FDA facilities at the White Oak Campus to implement an innovative detection method.

Their research approach incorporated DNA extraction from vaccine samples, followed by circular formation and introduction into E. coli cells. The presence of antibiotic-resistant bacterial colonies would indicate replication-competent DNA, a component that should be minimal or nonexistent in vaccine products.

Investigation of multiple Pfizer mRNA vaccine lots, including both monovalent and bivalent versions, revealed concerning results. The analysis showed DNA contamination levels reaching up to 470 times above WHO guidelines, with doses containing between 40 to 110 nanograms of residual DNA.

While commercial Pfizer batches showed no replication-competent DNA, they consistently contained DNA fragments approximately 35 base pairs long. The team also noted occasional instances of replication-competent DNA in both an in-house mRNA vaccine and a biosimilar variant.

Former Human Genome Project director Kevin McKernan called the findings a “bombshell.” He stated, “These findings are significant not just for what they reveal but for what they suggest has been concealed from public scrutiny. Why has the FDA kept these data under wraps?”

McKernan also highlighted potential limitations in the methodology: “The Qubit analysis can under-detect DNA by up to 70% when enzymes are used during sample preparation. Additionally, the Plasmid Prep kit used in the study does not efficiently capture small DNA fragments, further contributing to underestimation.”

Professor Nikolai Petrovsky, director of Vaxine Pty Ltd, termed the discovery a “smoking gun.” He noted, “It clearly shows the FDA was aware of these data. Given that these studies were conducted in their own labs under the supervision of their own scientists, it would be hard to argue they were unaware.”

Reflecting on the students’ achievement, Petrovsky added, “The irony is striking. These students performed essential work that the regulators failed to do. It’s not overly complicated—we shouldn’t have had to rely on students to conduct tests that were the regulators’ responsibility in the first place.”

This revelation follows Florida Surgeon General Dr. Joseph Ladapo’s December 6th letter to FDA Commissioner Califf and CDC Director Cohen, expressing concerns about DNA fragments in mRNA vaccines and potential genome integration risks.

Ladapo specifically highlighted concerns about lipid nanoparticles and SV40 promoter/enhancer DNA, writing, “Lipid nanoparticles are an efficient vehicle for delivery of the mRNA in the COVID-19 vaccines into human cells, and may therefore be an equally efficient vehicle for delivering contaminant DNA into human cells. The presence of SV40 promoter/enhancer DNA may also pose a unique and heightened risk of DNA integration into host cells.”

These findings echo a 2022 Swedish study published in the Journal of Clinical Medicine, which demonstrated Pfizer’s vaccine mRNA could modify human DNA within six hours. The study noted: “Our study shows that BNT162b2 can be reverse transcribed to DNA in liver cell line Huh7, and this may give rise to the concern if BNT162b2-derived DNA may be integrated into the host genome and affect the integrity of genomic DNA, which may potentially mediate genotoxic side effects.”

The Swedish research revealed rapid cellular changes, with high levels of foreign DNA detected in liver cells within hours of exposure, accompanied by swift gene expression alterations in affected cells.

 

RELATED ARTICLESMORE FROM AUTHOR